483P Pre-clinical and early clinical assessment of the safety and anti-tumor activity of RP12146, a PARP1/2 inhibitor in solid tumors

Autor: P. Tomczak, M. Kwiatek, D. Chraniuk, M. Kmiecik, I. Lugowska, M. Chełstowska, S. Eleswarapu, S. Veeraraghavan, K. Routhu, P. Barde, A. Nair
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S761
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2022.07.611
Databáze: OpenAIRE